Biobab AiBIO
Incheon
About Biobab AiBIO
Biobab AiBIO is a biotechnology company that develops drugs utilize artificial intelligence.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $14.1M
- Funding stage: Early Stage Venture
- Last round: Series A (Mar 2021)
- Website: baobabaibio.com
- Phone: +82 032 212 9770
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Medical, Pharmaceutical
Canonical: https://fsome.com/organization/biobab-aibio-18759 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.